From: Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
FEV1/FVC <0.7 (n = 149) | FEV1/FVC ≥0.7 (n = 227) | ||||
---|---|---|---|---|---|
n | (%) | n | (%) | P-value | |
Men | 69 | 46.3 | 74 | 32.6 | 0.007 |
Age ≥65 years | 82 | 55.0 | 70 | 30.8 | <0.001 |
Smoking | |||||
Current | 44 | 29.5 | 62 | 27.3 | <0.001a |
Former | 86 | 57.7 | 87 | 38.3 | |
Never | 19 | 12.8 | 78 | 34.4 | |
GP diagnosis | |||||
COPD only | 59 | 39.6 | 15 | 6.6 | <0.001a |
COPD and asthma | 54 | 36.2 | 38 | 16.7 | |
Asthma only | 36 | 24.4 | 174 | 76.7 | |
Other illness (GP reported) | |||||
Allergic rhinitis and/or eczema | 46 | 30.9 | 125 | 55.1 | <0.001 |
Cardiovascular disease | 64 | 43.0 | 58 | 25.6 | <0.001 |
Exacerbation in the previous year | 54 | 36.2 | 46 | 20.3 | 0.001 |
FEV1% predicted | |||||
<50 | 44 | 29.5 | 7 | 3.1 | <0.001a |
50–80 | 87 | 58.4 | 77 | 33.9 | |
≥80 | 18 | 12.1 | 143 | 63.0 | |
CCQ mean scoreb | |||||
<1 | 30 | 21.6 | 64 | 29.9 | 0.03a |
1–2 | 50 | 36.0 | 81 | 37.9 | |
≥2 | 59 | 42.4 | 69 | 32.2 |